Onglyza Heart Problems Topic of Upcoming FDA Advisory Committee
An FDA advisory committee will look at data indicating potential Onglyza heart problems at a meeting in April.
An FDA advisory committee will look at data indicating potential Onglyza heart problems at a meeting in April.
AstraZeneca and Bristol-Myers Squibb will unveil new studies on diabetes drugs at an upcoming conference.
The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic cancer from an entire class of diabetes drugs, which includes…